Over three million asthmatics have not been tested for the triggers that could cause a fatal attack, figures suggest.
Allergic asthma is the commonest form of the condition, accounting for 50% of adults and 90% of children.
A new study of over 5,000 asthma patients shows that only 1 in 3 have been allergy tested, even though 2017 NICE guidance for asthma treatment recommends specific IgE testing to identify allergens as soon as a formal asthma diagnosis has been made.
Every ten seconds someone in the UK has an asthma attack and around three people every day die as a result. The top ten triggers include grass pollen (1st) house dust mites (2nd) and cats (3rd).
Megan Winzer, 22, from Letchworth has suffered from asthma since she was one year old, she also has a severe nut allergy and has had three anaphylactic shocks in the past 10 years, resulting in intensive care admissions. “I know there’s link between asthma and allergy,” she says, “but I’ve never been offered a test and no one has explained the link.”
Over 50% of people who took part in the research believed that understanding their asthma triggers would help them to manage their condition. 90% of those who had been tested believed this was the case.
Dr Shuaib Nasser, Consultant in the Department of Allergy and Asthma at Cambridge University Hospitals NHS Foundation Trust, commenting of the research which was conducted on behalf of The British Society for Allergy & Clinical Immunology (BSACI) said “We know that triggers can be identified for many people with asthma – the attacks don’t come out of the blue.”
Patient knowledge of asthma triggers could reduce hospital admissions and save the NHS millions. The cost of asthma to the NHS is GBP 1.1 billion per year, of which over GBP 660 million is spent on prescription drugs. NHS data shows that there were more than 77,000 asthma-related hospital admissions in 2018, costing over GBP 120 million.
Endnotes
A group of 5,003 people (4,000 adults and 1,000 children) nationwide were surveyed between 10th – 31st October 2018. This real-world evidence study was based on a questionnaire produced by a Delphi-style group made up of the BSACI, Allergy UK and individual GPs.
Asthma: diagnosis, monitoring and chronic asthma management. November 2017.
https://www.nice.org.uk/guidance/ng80
The Reality of Asthma Care in the UK, p 21. By Lottie Renwick, Asthma UK, 2018. https://www.asthma.org.uk/578f5bcf/globalassets/get-involved…
Asthma & Allergy, Making the Connection; A Real-World Study by Dr Shuaib Nasser, 2019.
The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases. August 2016 https://bmcmedicine.biomedcentral.com/articles/10.1186/s1291…
Dr Shuaib Nasser is a consultant in Allergy and Asthma at Cambridge University Hospitals NHS Foundation Trust. He set up and chaired the BSACI Standards of Care Committee leading to the publication of National Allergy Guidelines. Dr Nasser was a key member of the Royal College of Physicians National Review of Asthma Deaths Steering Group, he chaired the NICE Drug Allergy Guidelines and is a leading expert of Asthma and Allergy in the UK.
IgE tests, or immunoglobulin E tests, measure the levels of IgE, a type of antibody. Antibodies are made by the immune system to protect the body from bacteria, viruses and allergens. IgE antibodies are normally found in small amounts in the blood, but higher amounts can be a sign that the body overreacts to allergens. This can lead to allergic reaction.
The British Society for Allergy & Clinical Immunology (BSACI) is the national, professional and academic society that represents the specialty of allergy at all levels. Its aim is to improve the management of allergies and related diseases of the immune system in the United Kingdom, through education, training and research.
Media relations activity for BSACI funded through an unrestricted educational grant from Thermo Fisher Scientific
